Achieve Life Sciences, Inc. (ACHV) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Achieve Life Sciences, Inc. (ACHV).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $2.61

Daily Change: -$0.03 / 1.15%

Daily Range: $2.56 - $2.90

Market Cap: $131,168,672

Daily Volume: 925,294

Performance Metrics

1 Week: 1.15%

1 Month: 11.39%

3 Months: 10.92%

6 Months: -21.66%

1 Year: -40.94%

YTD: -25.00%

Company Details

Employees: 25

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Selected stocks

American Express Company (AXP)

Amgen Inc. (AMGN)

Apple Inc. (AAPL)